Latest Publications

Share:

Telehealth Use Surges Around the World Amid COVID-19 (UPDATED)

During the coronavirus (COVID-19) pandemic, we have seen a dramatic shift from in-person visits to telehealth services around the globe, unveiling what may be the new normal for providing healthcare services....more

Telehealth Use Surges Around the World Amid COVID-19

During the coronavirus (COVID-19) pandemic, we have seen a dramatic shift from in-person visits to telehealth services around the globe, unveiling what may be the new normal for providing healthcare services....more

Unveiling and Preventing Common Expense Fraud Schemes in China

In this LawFlash, we outline the expense fraud scheme reported in a 2019 case involving the crime of illegal sale of “fapiaos,” examine some typical expense fraud schemes in China, and provide our practical takeaways with...more

China Publishes New Measure on Cybersecurity Review of Network Products and Services

The new measure, which will come into effect on June 1, 2020, will potentially affect operators of critical information infrastructures as well as their domestic and overseas suppliers. Affected companies should now take...more

Developing and Investing in Automotive Production in China

The growth of automobile production and sales in China, particularly in the realm of alternative fuel vehicles (New Energy Vehicles or NEVs), has been nothing short of explosive, experiencing a nearly 1,000-fold increase...more

Life Sciences International Review - Q2 2019

EU – REGULATORY - Brexit, Notified Bodies, and Medical Devices - The House of Commons Library published a briefing paper on June 12 on the UK’s product standards and safety marking compliance in light of Brexit. In the...more

Beware of Transfer Pricing Audit Risks in China

Chinese customs authorities have stepped up transfer pricing enforcement in recent years. Here are some of the steps multinational companies should take to address the enforcement risks....more

China to Audit Foreign and Domestic Drug Makers on Accounting Compliance

In an effort to drive down medical costs, the PRC Ministry of Finance has announced it will audit 77 randomly selected drug makers in China in order to examine the companies’ costs and profits and determine the reasonableness...more

Physician Speaking Fees Remain Focus of Commercial Bribery Regulation in China

The Administration for Market Regulation of Jing’an District in Shanghai (AMR) on May 7 announced an administrative penalty decision against the Shanghai branch of a multinational pharmaceutical company (the Branch) for...more

China Introduces Amendments to Address Fear of Forced Technology Transfer

China has long been criticized for having enacted various regulations allowing discriminatory technology licensing practices against foreign technology owners. These regulations restrict the ability of foreign technology...more

Amended PRC Individual Income Tax Law and Regulations Impact Expatriate Employees in China

The Amended Individual Income Tax Law has implications for both Chinese nationals and expatriates working in the People’s Republic of China. Notably, tax residency, and its accompanying individual income tax liability, will...more

New Rules in the PRC Focus on Underreporting, Underpayment Regarding Social Insurance Fees

Under new rules effective January 1, 2019, Chinese tax authorities will now collect social insurance fees on the actual income paid to employees based on the monthly reporting of income for individual income tax filings....more

China Creates ‘Special Channel’ for Fast-Track Approval of Some Foreign Drugs

Expanding on recent reforms allowing innovative pharmaceutical drugs to be approved on the basis of overseas clinical trial data, China’s National Medical Products Administration (NMPA) has created special channels for the...more

Chinese Authorities Appear to Increase Scrutiny on Marketing of Offshore Wealth Management Products

Under recent Chinese banking regulations, which include the increased regulation of asset and wealth management products, licensed commercial banks must have prior approval and licensing to engage in the marketing and sale of...more

Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery

A local regulator in Shanghai has recently fined a domestic medical device company for commercial bribery after determining that the company had unduly influenced a group of seven physicians when it paid them speaking fees to...more

8/10/2018  /  Bribery , China , Medical Devices , Physicians

China National Drug Administration Sets Guidelines for Overseas Drug Trial Data

In an effort to increase the availability of pharmaceutical treatments in China, the China National Drug Administration has recently released guidelines to allow pharmaceutical drugs that have already undergone clinical...more

China Releases First National List of Rare Diseases

The release of the rare diseases list, along with the allowance of foreign clinical data in new drug applications, is expected to substantially shorten the timeline and streamline the process for the approval of new orphan...more

China Announces Crackdown Campaign Against Unfair Competition Activities

China’s State Administration for Market Regulation recently announced an enforcement sweep to promote the implementation of its amended Anti-Unfair Competition Law. The crackdown campaign, which began in May and will continue...more

Impact of Chinese Government Restructuring on the Life Sciences Industry

On March 17, 2018, China’s National People’s Congress (NPC) approved a general plan proposed by China’s State Council to restructure certain Chinese government agencies. This restructuring plan affects a wide range of Chinese...more

5/17/2018  /  CFDA , China , Exports , Imports , Life Sciences

An Introductory Guide to Arbitration in Asia - March 2018

Commercial parties, when entering into a contractual relationship, will have to address three key issues when negotiating the dispute resolution (or jurisdiction) clause. First, whether to resolve those disputes by...more

China Publishes National Standard for Personal Data Protection

With increased concerns regarding the safety of individual personal information, the Chinese government has clarified its existing data privacy rules regarding the collection, processing, usage, and more of personal data....more

China Redefines Commercial Bribery and Increases Penalties

China amended its Anti-Unfair Competition Law on November 4, 2017—the first time the law has been amended since it was promulgated in 1993....more

Overseas investment by Chinese enterprises should pay attention to the risk of the U.S. Foreign Corrupt Practices Act

With the deepening of global economic integration, more and more Chinese enterprises go abroad to participate in local investment and economic construction. Among them, as an important part of the national economy, Chinese...more

CFDA Issues New Classification Catalogue for Medical Devices In China

The new catalogue, which becomes effective on August 1, 2018, is likely to have a significant impact on the registration, manufacturing, operation, and distribution of medical devices in China. ...more

10/23/2017  /  CFDA , China , Life Sciences , Medical Devices

China Drafts Legislative Rules Regarding Cross-border Data Transfers

The draft legislation provides further guidance on the regulations provided in the recent cybersecurity law, including definitions and details on the security assessments required for cross-border data transfers....more

77 Results
 / 
View per page
Page: of 4

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide